Valuation : SurModics

Market Cap 427M 369M 347M 316M 591M 40.37B 596M 4.11B 1.6B 20.64B 1.6B 1.57B 67.8B P/E 2023
-292x
P/E 2024 -47.3x
Enterprise Value 420M 363M 342M 311M 582M 39.72B 586M 4.05B 1.57B 20.31B 1.58B 1.54B 66.71B EV / Sales 2023
3.33x
EV / Sales 2024 4.33x
Free-Float
99.63%
Yield 2023 *
-
Yield 2024 -
1 year 25.87
Extreme 25.87
43
3 years 25.17
Extreme 25.17
43
5 years 16
Extreme 16
60.55
10 years 16
Extreme 16
82.35
Manager TitleAgeSince
Chief Executive Officer 67 18/11/2025
Director of Finance/CFO 53 18/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 18/11/2025
Director/Board Member 53 18/11/2025
Date Insider Type Main position Quantity % Market Cap. Importance
19/11/25 Issuer sale

Executive/Senior Manager

171,148 1.1970%
19/11/25 Issuer sale

Director

35,847 0.2507%
19/11/25 Issuer sale

Controller/Auditor

24,311 0.1700%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%-.--%+25.16%+18.73% 615M
+1.41%-3.18%-15.97%+7.41% 188B
+0.15%+0.17%-1.23%+12.24% 118B
+1.63%+2.61%+14.08%+92.25% 63.16B
+0.39%+0.18%+25.53%+49.09% 52.01B
+0.21%-1.41%-0.33%-32.66% 50.97B
-0.50%+0.82%+20.71%-11.98% 34.02B
+3.39%+4.97% - - 30.8B
+1.18%-2.08%+40.57%-15.96% 23.83B
+0.22%-3.32%-5.97%+13.95% 23.45B
Average +0.80%-0.44%+11.40%+14.79% 58.52B
Weighted average by Cap. +0.83%-1.72%+1.07%+16.42%

Financials

2023 2024
Net sales 133M 114M 108M 98.17M 183M 12.52B 185M 1.28B 495M 6.4B 498M 487M 21.03B 126M 109M 102M 93.35M 174M 11.91B 176M 1.21B 471M 6.09B 473M 463M 20B
Net income -1.54M -1.33M -1.25M -1.14M -2.13M -145M -2.14M -14.78M -5.74M -74.18M -5.77M -5.64M -244M -11.54M -9.96M -9.38M -8.55M -15.97M -1.09B -16.09M -111M -43.1M -557M -43.34M -42.39M -1.83B
Net Debt -12.1M -10.44M -9.83M -8.96M -16.75M -1.14B -16.87M -116M -45.19M -584M -45.44M -44.45M -1.92B -6.87M -5.93M -5.58M -5.09M -9.51M -649M -9.58M -66.1M -25.65M -332M -25.8M -25.23M -1.09B
Logo SurModics
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Employees
389
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. SRDX Stock